See All Slides - tctmd.com

Slides

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

Same-Day Discharge After Radial PCI: Protocols and Practice

Presenter: Sunil Rao

October 23, 2012

Presentation TCT 2012

TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study

Presenter: Paul Gurbel

October 23, 2012

Presentation TCT 2012

Practice Trends in the United States: Nonadherence to the Mitral Valve Guidelines

Presenter: James Gammie

October 23, 2012

Presentation TCT 2012

TCT-28. Is the Rate of Femoral Access Site Complications Increased in the Hands of 'Radialists'?

Presenter: Stefano Rigattieri

October 23, 2012

Presentation TCT 2012

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

TCT-47. Two-year Clinical Outcome of the TWENTE Trial, A Randomized Controlled Trial Comparing Second-generation Zotarolimus-eluting Resolute Stents vs. Everolimus-eluting...

Presenter: Clemens von Birgelen

October 23, 2012

Presentation TCT 2012

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 23, 2012

Presentation TCT 2012

Introduction(8)

Presenter: Elizabeth Jackson

October 23, 2012

Presentation TCT 2012

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Presenter: Allan Schwartz

October 23, 2012

Advertisement

Slides

Autologous Cardiac Stem Cells in VAD Patients

Same-Day Discharge After Radial PCI: Protocols and Practice

TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study

Practice Trends in the United States: Nonadherence to the Mitral Valve Guidelines

TCT-28. Is the Rate of Femoral Access Site Complications Increased in the Hands of 'Radialists'?

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

TCT-47. Two-year Clinical Outcome of the TWENTE Trial, A Randomized Controlled Trial Comparing Second-generation Zotarolimus-eluting Resolute Stents vs. Everolimus-eluting...

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Introduction(8)

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content